Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 10 records, 1 pages
Search For: Asenapine
Global Asenapine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
02 Jan 2024
Pharma & Healthcare
According to our (Global Info Research) latest study, the global Asenapine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
Global Saphris (Asenapine) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
09 Jan 2024
Pharma & Healthcare
According to our (Global Info Research) latest study, the global Saphris (Asenapine) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
Global Asenapine Maleate API Supply, Demand and Key Producers, 2024-2030
03 Mar 2024
Chemical & Material
The global Asenapine Maleate API market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
Global Asenapine Maleate API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
10 Jan 2024
Chemical & Material
According to our (Global Info Research) latest study, the global Asenapine Maleate API market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
Global Asenapine Supply, Demand and Key Producers, 2023-2029
14 Feb 2023
Pharma & Healthcare
Asenapine, sold under the trade names Saphris and Sycrest among others, is an atypical antipsychotic medication used to treat schizophrenia and acute mania
USD4480.00
Add To Cart
Global Asenapine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
07 Jan 2023
Pharma & Healthcare
Asenapine, sold under the trade names Saphris and Sycrest among others, is an atypical antipsychotic medication used to treat schizophrenia and acute mania
USD3480.00
Add To Cart
Global Saphris (Asenapine) Supply, Demand and Key Producers, 2023-2029
22 Feb 2023
Pharma & Healthcare
This report studies the global Saphris (Asenapine) production, demand, key manufacturers, and key regions.
USD4480.00
Add To Cart
Global Saphris (Asenapine) Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
08 Jan 2023
Pharma & Healthcare
According to our (Global Info Research) latest study, the global Saphris (Asenapine) market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
USD3480.00
Add To Cart
Global Asenapine Maleate API Supply, Demand and Key Producers, 2023-2029
04 Feb 2023
Chemical & Material
The global Asenapine Maleate API market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
Global Asenapine Maleate API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
11 Jan 2023
Chemical & Material
Asenapine maleate acts as an antimanic. It belongs to the family of dibenzoxepinopyrrolidines. Asenapine is considered to be a weak inhibitor of cytochrome P450 2D6 (CYP2D6). It increases the level of dopamine, norepinephrine and acetylcholine in brain.
USD3480.00
Add To Cart
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
Search For: Asenapine
Total: 10 records, 1 pages
According to our (Global Info Research) latest study, the global Asenapine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
According to our (Global Info Research) latest study, the global Saphris (Asenapine) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
The global Asenapine Maleate API market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global Asenapine Maleate API market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
Asenapine, sold under the trade names Saphris and Sycrest among others, is an atypical antipsychotic medication used to treat schizophrenia and acute mania
USD4480.00
Add To Cart
Asenapine, sold under the trade names Saphris and Sycrest among others, is an atypical antipsychotic medication used to treat schizophrenia and acute mania
USD3480.00
Add To Cart
This report studies the global Saphris (Asenapine) production, demand, key manufacturers, and key regions.
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global Saphris (Asenapine) market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
USD3480.00
Add To Cart
The global Asenapine Maleate API market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
Asenapine maleate acts as an antimanic. It belongs to the family of dibenzoxepinopyrrolidines. Asenapine is considered to be a weak inhibitor of cytochrome P450 2D6 (CYP2D6). It increases the level of dopamine, norepinephrine and acetylcholine in brain.
USD3480.00
Add To Cart
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>